Lin KT

Title : A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma - Lin_2018_Genome.Res_28_275

Author(s) : Lin KT , Ma WK , Scharner J , Liu YR , Krainer AR

Ref : Genome Res , 28 :275 , 2018

Abstract :

PubMedSearch : Lin_2018_Genome.Res_28_275

PubMedID: 29449409

Gene_locus related to this paper: human-AFMID

Title : 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV - Tsu_2006_J.Med.Chem_49_373

Author(s) : Tsu H , Chen X , Chen CT , Lee SJ , Chang CN , Kao KH , Coumar MS , Yeh YT , Chien CH , Wang HS , Lin KT , Chang YY , Wu SH , Chen YS , Lu IL , Wu SY , Tsai TY , Chen WC , Hsieh HP , Chao YS , Jiaang WT

Ref : Journal of Medicinal Chemistry , 49 :373 , 2006

Abstract :

PubMedSearch : Tsu_2006_J.Med.Chem_49_373

PubMedID: 16392822

Lin KT

References (2)

1. A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma - Lin_2018_Genome.Res_28_275

2. 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV - Tsu_2006_J.Med.Chem_49_373